title: Pyroglutamyl aminopeptidase I, as a drug metabolizing enzyme, recognizes xenobiotic substrates containing L-2-oxothiazolidine-4-carboxylic acid.
abstract: Pyroglutamyl aminopeptidase I (PAP-I) is known for specifically removing the L-pyroglutamate (L-pGlu) residue from the amino terminus of L-pGlu proteins and peptides. In general, substrate recognition of PAP-I as to L-pGlu moiety is tightly regulated. However, we recently identified PAP-I as a metabolic enzyme of an organic nitrate compound, RS-7897, which contains L-2-oxothiazolidine-4-carboxylic acid (L-OTCA). L-OTCA is a latent sulfhydryl group, which has moiety structurally related to L-pGlu. In this study, we investigated the substrate specificity of PAP-I toward modified L-pGlu-containing substrates using recombinant rat, mouse and human PAP-Is. PAP-I was tolerant of replacement of a carbon atom at the 4-position of the L-pGlu moiety by a sulfur atom (L-OTCA), an oxygen atom (L-2-oxooxazolidine-4-carboxylic acid, L-OOCA) and an NH group (L-2-oxoimidazolidine-4-carboxylic acid, L-OICA). The K(m) values for rat PAP-I in hydrolyzing L-pGlu-L-Ala, L-OTCA-L-Ala, L-OOCA-L-Ala and L-OICA-L-Ala were 0.057, 0.43, 0.71 and 0.42 mM, respectively. Similar results were observed in mouse and human PAP-Is as well. Moreover, the hydrolysis of RS-7897 in rat and mouse liver cytosols were both completely inhibited by an antibody against rat PAP-I, strongly suggesting that PAP-I is solely involved in the hydrolysis of L-OTCA-containing compounds in rat and mouse liver cytosols.
authors.affiliation: Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co. Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan. koujia@shina.sankyo.co.jp
authors.forename: Koji
authors.initials: K
authors.lastname: Abe
authors.forename: Fujio
authors.initials: F
authors.lastname: Saito
authors.forename: Makiko
authors.initials: M
authors.lastname: Yamada
authors.forename: Taro
authors.initials: T
authors.lastname: Tokui
mesh_terms: D000818:Animals; D002244:Carbon / Q000378:metabolism; D003600:Cytosol / Q000201:enzymology / Q000378:metabolism; D004926:Escherichia coli / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D066298:In Vitro Techniques; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D051379:Mice; D009566:Nitrates / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011751:Pyroglutamyl-Peptidase I / Q000378:metabolism*; D011761:Pyrrolidonecarboxylic Acid; D051381:Rats; D013379:Substrate Specificity; D013455:Sulfur / Q000378:metabolism; D013844:Thiazoles / Q000378:metabolism*; D053778:Thiazolidines; D015262:Xenobiotics / Q000378:metabolism*
chemical_list: D009566:Nitrates; D004364:Pharmaceutical Preparations; D013844:Thiazoles; D053778:Thiazolidines; D015262:Xenobiotics; D013455:Sulfur; D002244:Carbon; D011751:Pyroglutamyl-Peptidase I; D010100:Oxygen; D011761:Pyrrolidonecarboxylic Acid; C029536:2-oxothiazolidine-4-carboxylic acid